OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 5.75
0.00 (0.00%)
Aug 14, 2026, 4:02 PM GMT
OptiBiotix Health Market Cap
OptiBiotix Health has a market cap or net worth of 5.94 million as of August 14, 2026. Its market cap has decreased by -43.90% in one year.
Market Cap
5.94M
Enterprise Value
4.90M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.75
ChartMarket Cap Chart
Since August 5, 2014, OptiBiotix Health's market cap has decreased from 6.46M to 5.94M, a decrease of -8.02%. That is a compound annual growth rate of -0.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.94M | -14.81% |
| Dec 31, 2025 | 6.97M | -60.45% |
| Dec 31, 2024 | 17.63M | -27.73% |
| Dec 29, 2023 | 24.39M | 101.89% |
| Dec 30, 2022 | 12.08M | -70.13% |
| Dec 31, 2021 | 40.45M | -20.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 13.82M |
| Fusion Antibodies | 13.14M |
| Palatin Technologies | 12.87M |
| Genflow Biosciences | 12.12M |
| Solvonis Therapeutics | 10.21M |
| Cizzle Biotechnology Holdings | 7.01M |
| CRISM Therapeutics | 5.83M |
| Thalia Therapeutics | 5.62M |